Reference
ICER. Institute for Clinical and Economic Review report finds evidence limited on treatments for tardive dyskinesia; discounts of up to 90% needed to align cost of drugs with benefit to patients. Internet Document : 21 Nov 2017. Available from: URL: https://icer-review.org/announcements/tardive-dyskinesia-evidence-report/
Rights and permissions
About this article
Cite this article
Treatments for TD: limited evidence, high cost. PharmacoEcon Outcomes News 792, 4 (2017). https://doi.org/10.1007/s40274-017-4527-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4527-1